Publication | Closed Access

Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype

Clinical OutcomeSpecific Mutant KrasMedicinePathologyCancer GenomicsBronchial NeoplasmCancer TreatmentMolecular DiagnosticsCancer GeneticsOncologyRadiation OncologyLung CancerCancer Research